ABSTRACT. The vesicular integral membrane protein VIP36 belongs to the family of animal lectins and may act as a cargo receptor trafficking certain glycoproteins in the secretory pathway. Immunoelectron microscopy of GH3 cells provided evidence that endogenous VIP36 is localized mainly in 70-100-nm-diameter uncoated transport vesicles between the exit site on the ER and the neighboring cis-Golgi cisterna. The thyrotrophinreleasing hormone (TRH) stimulation and treatment with actin filament-perturbing agents, cytochalasin D or B or latrunculin-B, caused marked aggregation of the VIP36-positive vesicles and the appearance of a VIP36-positive clustering structure located near the cis-Golgi cisterna. The size of this structure, which comprised conspicuous clusters of VIP36, depended on the TRH concentration. Confocal laser scanning microscopy confirmed the electron microscopically demonstrated distribution and redistribution of VIP36 in these cells. Furthermore, VIP36 colocalized with filamentous actin in the paranuclear Golgi area and its vicinity. This is the first study to show the ultrastructural distribution of VIP36 in the early secretory pathway in GH3 cells. It suggests that actin filaments are involved in glycoprotein transport between the ER and cis-Golgi cisterna by using the lectin VIP36.
The animal lectin family includes Emp47p (Schröder et al., 1995) and endoplasmic reticulum-Golgi intermediate compartment (ERGIC)-53. The latter proved to be a mannose-specific lectin and was localized to the ERGIC (Appenzeller et al., 1999) . Recently, VIP36 was found to be partially colocalized with coatomer and involved in trafficking along the secretory pathway (Füllekrug et al., 1999; Dahm et al., 2001) . Therefore, it has been hypothesized that VIP36 acts as a cargo receptor facilitating the transport of certain glycoproteins. In order to explore this possibility, we developed a very specific antibody against the N-terminus of VIP36 (lumenal tail) and a suitable strategy for immunoelectron microscopic analysis of VIP36 in cells. The ultrastructural distribution of VIP36 in GH3 cells was limited to within the transport vesicles and the ERGIC structure between the ER and Golgi apparatus, which suggests that the lectin VIP36 functions as a receptor that facilitates transport of a glycoprotein cargo from the ER to the cisGolgi. Immunogold particles were observed in uncoated transport vesicles (arrows) with 70-100 nm diameter situated between the ER and the cis-Golgi cisterna. G, Golgi complex. b, a part of a cell treated with cytochalasin D. Cytochalasin D increased the number of aggregates of VIP36-containing vesicles near a cis-face stack of the Golgi apparatus (G). These aggregates seemed to be the clusters (C) composed of a number of VIP36-positive vesicles. c, a part of TRH-stimulated cell pretreated with cytochalasin D. TRH (2 µM) significantly increased the area occupied by VIP36-positive clusters (C). Immunogold particles (arrow) were clearly observed only in the buds on the rough ER (rER), showing the rER exit site, and no gold particles were found in the lumens of the normal cisternae of the rER or the Golgi apparatus (G). d-g, immunofluorescence micrographs of VIP36 in GH3 cells. d, a control cell. VIP36 was widely distributed in the cytoplasm from the paranuclear regions to the peripheral cytoplasmic structures. e, a cell stimulated by TRH (2 µM). There were no significant differences between the VIP36 distributions in TRH-stimulated (e) and non-stimulated (d) GH3 cells. f, a cell treated with cytochalasin D. Cytochalasin D caused the redistribution of VIP36, resulting in patchy structures (arrow) in the cytoplasm of GH3 cells. g, a TRH-stimulated cell pretreated with cytochalasin D. TRH caused large patchy structures (arrow). Bars: a-c=0.5 µm, d-g=3 µm
Materials and Methods

Reagents and antibodies
The cell culture medium was obtained from Gibco (USA). Anti-VIP36 polyclonal antibodies against the lumenal tail of VIP36, the characteristics of which have been described by Hara-Kuge et al. (2002) , were raised in rabbits in our laboratory. It should be mentioned that our anti-VIP36 antibodies have never been found to cross-react with ERGIC-53. The used antibodies had been confirmed to be very specific to VIP36 (Hara-Kuge et al., 2002; Shimada et al., 2003) . Anti-ERGIC-53 antibody against the synthetic peptide of the amino acid sequences (31-55) of near N-terminus of ERGIC-53 was raised in rabbits in our laboratory. FITC-and Texas-Red-labeled phalloidins were purchased from Sigma (USA). An anti-type V myosin antibody was a gift from Dr. R. Ishikawa (Gunma University School of Medicine) (Ishikawa et al., 1998) . Nocodazole, vinblastine, colcemid, cyotochalasins B and D (Wako Pure Chem., Japan) and latrunculin-B (Alexis Corporation, USA) were purchased, rapidly dissolved with 10% DMSO in PBS and these stock solutions were stored at -80°C in darkness. Thyrotrophin-releasing hormone (TRH) was obtained from Sigma. The following secondary antibodies were used: goat anti-rabbit immunoglobulin (Ig) G coupled to FITC or Texas Red (Cortex Biochem, Inc., USA), anti-mouse IgG coupled to FITC or Texas Red and anti-rabbit IgG conjugated with 10-or 15-nm-gold particles (EY Laboratories Inc., USA).
Cell culture
All the chemical reagents used were of analytical grade. GH3 cells, which are prolactin (PRL)-and growth hormone (GH)-producing rat pituitary adenoma cells, were provided by Dr. R. Horiuchi (Gunma University School of Medicine). They were grown in DMEM supplemented with sodium pyruvate (1 mM), glutamine (2 mM), nonessential amino acids (200 µM), epidermal growth factor (20 nM), 10% horse serum, 2.5% fetal calf serum, 48 mg l -1 penicillin and 100 mg l -1 streptomycin on a glass slide in 100-mm fibronectin-and collagen type I-coated plastic culture dishes at 37°C in a 5% CO2 atmosphere. After incubation for 6 hr, in order to remove round-shaped cells that were not suitable for morphological observation, the dishes were flushed with a swift water current via a pipette, which removed 60-70% of the cells. Then, the dishes were filled with the same culture medium and kept in an incubator, under the conditions described above, for three days. For three days the remaining cells became 80% confluent and appeared to adhere tightly to the glass slides. The culture medium was discarded and the cells were incubated for further 30 min at 37°C in fresh medium containing the following drugs (cytoskeleton toxins): a microtubule-disrupting agent (100 µM vinblastine, 1 µM colcemid or 20 µM nocodazole) or an actin filament-depolymerization agent (2 µM cytochalasin D, 1 mM latrunculin-B or 1 µM cytochalasin B). Control cell cultures were incubated in culture medium containing the same concentration of DMSO as the test media. Two groups of cells were stimulated with TRH 10 min after applying the cytoskeleton toxin by adding TRH to the culture medium to produce a final concentration of 100 nM or 2 µM and then culture was continued for a further 20 min. Finally, each culture medium was collected for radioimmunoassay of rat GH and PRL, according to the method described previously (Shimada et al., 1988) .
Immunoelectron microscopy
Cells cultured on glass slides were fixed for 5 min with 5% acrolein in 1/15 M phosphate buffer (PB), pH 7.4, at 37°C, washed three times with PB, then fixed with PB containing 1% paraformaldehyde, 0.125% glutaraldehyde and 0.1% picric acid for 1 hr at 37°C followed by 3 hr at 4°C (Shimada et al., 1998; 2003) . The cells were postfixed with 1% osmium tetroxide and 7% sucrose in PB for 1 hr at 4°C, dehydrated with a graded ethanol series at 0°C, embedded in Lowicryl K4M and cured under ultraviolet light for 3 days at -35°C. In order to quench any remaining acrolein, ultrathin sections were treated with 3% hydrogen peroxide at room temperature for 10 min, washed three times with water and then treated with 0.1% ammonium chloride for 10 min. After washing well with water, both sides of the ultrathin sections were treated with 10% normal goat serum at room temperature for 1 hr and incubated with the anti-VIP36 antibody (1:200) in 100 mM phosphate buffered saline (PBS), pH7.4, containing 1% BSA for 24 hr at 4°C. After rinsing well with PBS, the sections were incubated for 1 hr with 10-nm colloidal gold-labeled anti-rabbit IgG (1:200) in PBS containing 1% BSA at room temperature, followed by rinsing with PBS and then water. For double immunostaining of electron microscopy, another side of the thin section was stained with the anti-ERGIC-53 antibody (1:1000) and then 15-nm colloidal goldlabeled anti-rabbit IgG (1:200). Finally, sections were stained with uranyl acetate and lead citrate and examined with an electron microscope (Hitachi H-7500). For morphometric analysis, only sections cut through the center of nucleus in GH3 cells were examined and they were randomly selected. Up to 300 cells per experimental group were examined and the areas composed of clusters of VIP36-positive vesicles were measured automatically by the Hitachi area calculation software system coupled to the CCD camera. The outline of each VIP36-positive cluster was traced on the computer screen and the total surrounding area was calculated auto- Cytochalasin D+TRH (100 nM) 3.9±0.9
Cytochalasin D+TRH (2 µM) 4.5±0.8
Only the sections cut through the center of nucleus in GH3 cells were examined. Each experimental group contained 300 different cells. Narrow areas less than 13,000 nm 2 were not calculated. Most of the narrow areas were single vesicles or an edge of a cluster. All values are means±S.D.. ND, not detected. matically. It should be mentioned that surrounding areas less than 13,000 nm 2 could not be measured exactly. Therefore, we omitted all the data from narrow areas less than 13,000 nm 2 , most of which were found to be single vesicles or an edge of a cluster.
Confocal laser scanning microscopy
For comparison with the electron microscopic data, we applied the same fixative procedure to the cells subjected to immunofluorescence analysis. As described above, these cells were fixed with acrolein then paraformaldehyde, glutaraldehyde and picric acid and washed with PBS. Hydrogen peroxide and ammonium chloride were used to quench any aldehyde remaining in the specimens. The cells were permeated with 1% Triton X-100 in PBS containing 1% BSA for 1 hr, treated with 10% normal goat serum for 1 hr and incubated with the required appropriately diluted antibody or cocktail of antibodies {anti-VIP36 (1:200), anti-actin (1:100), or anti-myosin type V (1:100)} for 24 hr at 4°C. After washing with PBS, the cells were incubated with the required fluorescence-labeled secondary antibody (1:100) for 1 hr at 20°C. Some of the specimens were then treated with fluorescencelabeled phalloidin (diluted 1:1000 with PBS) at 4°C for 1 hr and all the specimens were washed, mounted in 50% glycerol in Tris-HCl buffer (pH 8.6) containing 50 mg ml -1 1,4-diazabicyclo-octane (Aldrich Chemical, USA), which was used as an anti-bleaching agent. The confocal laser scanning microscopy (Olympus, LSM300) and double-labeling experimental data were obtained simultaneously to exclude any artifacts due to sequential acquisition. Both channels were adjusted to ensure that the maximum fluorescence intensity remained within the recording range.
Immunoblot analysis
Using the method described by Hara-Kuge et al. (2002) , GH3 cells were lysed by incubation on ice for 30 min in lysis buffer (1% NP-40 and 150 nM NaCl in 50 mM Tris-HCl buffer, pH 7.0) containing protease inhibitors. The lysate was centrifuged at 3000 rpm for 10 min at 4°C and the resulting supernatant was referred to as the detergent extract. The proteins were separated by electrophoresis on 15% polyacrylamide gel and transferred to nitrocellulose membranes. The VIP36 protein was detected with the anti-VIP36 antibody followed by an HRP-conjugated secondary antibody and visualized with Chemiluminescence Reagent (Amersham Pharmacia Biotech Ltd, UK).
Results
GH3 cells showed well-developed ER in the cytoplasm and Golgi apparatus. The latter consisted of three to five cisternae, those were arranged in typical stacks composed of a cis-face to a trans-face according to polarity. Almost all the ER membranes were identified definitely as rough ER (rER) and the rER cisternal space contained material of moderate electron density.
In both normal and TRH-stimulated GH3 cells, VIP36 was observed in the uncoated vesicles with 70-100 nm diameter situated between the exit site on the ER and the neighboring cis-Golgi cisterna (Fig. 1a) . Unlike normal rat GH-secreting pituitary glandular cells, GH3 cells constitutively secrete two hormones, GH and PRL, without hypothalamic stimulating hormone. However, when the cells were cultured in the presence of TRH (2 µM) for 10 min, the steady-state secretion of GH and PRL into the surrounding medium was up-regulated 1.8-and 2.3-fold, respectively.
Cytochalasin D significantly caused the clusters of aggregates of VIP36-containing transport vesicles near a cis-face stack of the Golgi apparatus (Fig. 1b) . These aggregates seemed to be clusters composed of a number of VIP36-positive vesicles, which were situated between the rER and the cis-Golgi apparatus.
Treatment with latrunculin-B caused the same redistribution of VIP36 (data not shown). TRH significantly increased the area occupied by VIP36-positive clusters in GH3 cells pretreated with cytochalasin D (Fig. 1c) . Furthermore, the total area occupied by these clusters was dependent on the concentration of TRH (Table I) .
Immunogold particles were observed only in the buds on the rER, probably showing the rER exit site, and no gold particles were found in the lumens of the normal cisternae of the rER (Fig. 1a-1c) .
Immunofluorescence microscopy showed that VIP36 was widely distributed in the cytoplasm from the paranuclear regions to the peripheral cytoplasmic structures, which were very similar to those of our previous study on MDCK cells VIP36 (a, d, g ) and cytoskeletal proteins (b, e, h) in GH3 cells. Filamentous actin was stained by Texas Red-labeled phalloidin (b, e), and myosin was stained by anti-type V myosin antibody (h). Colocalization of VIP36 and cytoskeletal proteins was displayed as yellow in the colored overlays (c, f, i). a-c, the bottom of a cell. No colocalization was observed at the cell peripheries or along stress fiber-like structure (arrow) in GH3 cells. d-f, the center of the cell shown in a-c. Marked but not complete overlap of VIP36 and filamentous actin was observed in the paranuclear region of GH3 cells. g-i, a partial colocalization of VIP36 (g) and type V myosin (h). Bar: a-i=3 µm (Fig. 1d) . The immunofluorescence analysis revealed no significant difference between the VIP36 distributions in TRH-stimulated and non-stimulated GH3 cells (Fig. 1d, 1e) . Cytochalasin D caused redistribution of VIP36, resulting in patchy structures in the cytoplasm of GH3 cells (Fig. 1f,  1g) .
In an attempt to investigate the colocalization of cytoskeletal proteins, we compared the distributions of VIP36 with those of actin microfilaments and myosin (Fig. 2a-2i) . In normal GH3 cells, filamentous actin was present in the following three structures: 1) the stress fiber-like structure at the bottom of the cell (Fig. 2b) , 2) the surface plasma membrane periphery (Fig. 2b) and 3 ) paranuclear distribution sometimes showing ring-shaped morphology (Fig. 2e) . Marked but not complete overlap of VIP36 and filamentous actin in GH3 cells was observed (Fig. 2a-2f ). Colocalization of VIP36 and filamentous actin was obvious in the paranuclear regions, but did not occur along stress fibers or at the cell peripheries (Fig. 2c, 2f ). Partial colocalization of VIP36 and type V myosin was also observed in the paranuclear regions of GH3 cells (Fig. 2g-2i ).
Immunoblot analysis of VIP36 in GH3 cells yielded a strong immunopositive single band with a molecular mass of about 36 kDa, although there were no significant differences between the amounts of VIP36 in cells cultured in the absence or presence of cytochalasin D (Fig. 3) . TRH slightly increased VIP36 in GH3 cells pretreated with cytochalasin D (Fig. 3) .
The double immunostaining of electron microscopy showed partial colocalization of ERGIC-53 and VIP36 in the transport vesicles and the clusters (Fig. 4a, 4b ).
Discussion
Newly synthesized secretory and membrane proteins exit the ER in transport vesicles targeted to the Golgi apparatus (Majoul et al., 2001) . Vesicular transport is often accompanied by post-translational modifications, such as glycosylation of the cargo proteins, until they reach the Golgi apparatus (Girod et al., 1999; Deitz et al., 2000; Sato et al., 2001) . The protein transport and sorting system is one of the most interesting subjects in the study of vesicular protein traffic processes, but its molecular mechanisms remain largely unresolved.
Recently, intracellular lectins were demonstrated to play some important roles in vesicular transport (Hauri et al., 2000) . GM130 (Seemann et al., 2000) and GRASPs (Short et al., 2001) are located primarily at the cis-pole of the Golgi stacks, where they may function in the incorporation of the ER-derived membranes into the Golgi apparatus. The intracellular lectins calnexin and calreticulin are chaperons involved in quality control of newly synthesized glycoproteins in the ER. Other intracellular lectins, such as Emp47p and ERGIC-53, may act as receptors for cargo glycoproteins in the ER-to-Golgi transport vesicles (Schröder et al., 1995; Appenzeller et al., 1999) . Another putative cargo receptor belongs to the p24 family (Shimoni et al., 2000) . The present study showed that an intracellular lectin, VIP36, acting as a transmembrane cargo receptor, is also involved in the vesicular transport system and may sort certain glycoproteins between the rER and the Golgi apparatus (Dahm et al., 2001) , as do ERGIC-53 (Appenzeller et al., 1999) , the KDEL-receptor and the p24 family (Shimoni et al., 2000) . Some newly synthesized secretory and/or membrane proteins that exit the ER in transport vesicles are targeted to the cis-Golgi in combination with the lectin VIP36.
In GH3 cells, electron microscopic data showed the distribution of VIP36 was limited to the following three early secretory portions: 1) buds on rER exit site, 2) transport vesicles and 3) the ERGIC-like structures. This raises the question whether the limited intracellular distribution of VIP36 is common to various types of cell. We have examined the localization of VIP36 in various tissues and cells from rats and human subjects. In many endocrine cells, including the pituitary gland, the distribution of VIP36 was limited to the pre-Golgi early secretory pathway, as we found it was in GH3 cells in this study. However, some endocrine cells and many exocrine cells, including amylase-secreting acinar cells (parotid gland, pancreas and submandibular gland), goblet cells (small and large intestine) and secretory cells in lacrimal and thyroid glands, showed VIP36 immunoreactivity along the post-Golgi secretory pathway (Shimada et al., 2003) . Therefore, we suggest that the lectin VIP36 is involved not only in vesicular transport from the ER to the Golgi complex but also from the TGN to the plasma membrane in some cells. In order to clarify the function of VIP36, further investigations on a wide variety of cells should be conducted.
We treated cells with two different types of actin filament-disrupting agent, cytochalasins and latrunculin-B. The results suggested that not only microtubules but also actin filaments participate in the traffic of VIP36-positive vesicles between the rER and the Golgi apparatus. Research over many years has demonstrated that the motors which position and organize the ER and Golgi apparatus, as well as those that move membranes back and forth between these organelles, are microtubules (Bloom and Goldstein, 1998; Allan and Schroer, 1999; Mironov et al., 2001; Ward et al., 2001) and microtubule-based motors, such as kinesin II (Le Bot et al., 1998) , KIF1C (Dorner et al., 1998) and Rabkinesin6 (Echard et al., 1998) . The proteins exported from the ER have been reported to be incorporated into transport complexes, which are moved by cytoplasmic dynein towards the centrosome where they deliver their contents to the Golgi apparatus (Milisav, 1998) . Notably, in our present electron microscopic experiment on GH3 cells, the centrosome with its pair of centrioles was usually located near the Golgi apparatus, and microtubules were occasionally found between the rER and the Golgi appara-tus. In view of the properties of the microtubule distribution system, we had speculated that microtubule-disrupting agents, such as vinblastine, colcemid and nocodazole, would cause cessation of VIP36 transport and result in redistribution of VIP36, whereas actin filament-disrupting agents would not have these effects. Unexpectedly, we Fig. 4 . Partial colocalization of VIP36 (10-nm gold particles) and ERGIC-53 (15-nm gold particles) in transport vesicles between the endoplasmic reticulum and the Golgi appartus in GH3 cells. a, a part of a control GH3 cell. Colocalization of VIP36 and ERGIC-53 was observed in some uncoated vesicles (arrows) with 70-100 nm diameter situated between the ER and the cis-Golgi cisterna. G, Golgi complex. b, a part of TRH-stimulated cell pretreated with cytochalasin D. TRH increased the number of aggregates of VIP36-containing vesicles near a cis-face stack of the Golgi apparatus (G). These aggregates seemed to be the clusters (C) composed of a number of both VIP36-and ERGIC-53-positive vesicles. M, mitochondria. Bars: 0.3 µm found that, at very low concentrations, actin filament-disrupting agents induced dramatic changes in the distribution of VIP36. Ultrastructurally, microtubule-disrupting agents caused morphological changes in the structures of cell organelles: the stacks of the Golgi apparatus swelled and disassembled, and the cisternae of the rER became swollen. Unfortunately, we could not be sure which ultrastructural site was the cis-or trans-cisternal membrane of the Golgi apparatus in GH3 cells. It is well known that microtubules and microtubule-based motors are directly involved in subcellular positioning and membrane dynamics of the Golgi complex. In the present study, we could not confirm the role of microtubules, because the structures of the cell organelles were not conserved, making precise identification impossible.
Why is the aggregate of VIP36-positive vesicles exaggerated upon treatment with TRH in this paper? When cells were cultured in the presence of TRH (2 µM) for 10 min, the steady-state secretion of GH and PRL into the surrounding medium was up-regulated 1.8-and 2.3-fold, respectively. We speculated that VIP36 might play a role in hormone secretion in GH3 cells. VIP36 is a highly mannosespecific animal lectin, and might work as cargo receptors of their prohormones. Stimulation by TRH caused an accumulation of VIP36-positive vesicles during treatment with cytochalasin D. Further investigations are required to clarify the relationship between hormones and VIP36. A body of experimental evidence (De Pina and Langford, 1999; Enrique et al., 1999; Catlett et al., 2000) indicates that actin and actin-binding proteins might also be involved in the traffic between the ER and Golgi complex (Terasaki et al., 1990, Liebe and Menzel, 1995; Boevink et al., 1998) . In many cases, microtubules provide the tracks for long distance movement, while actin is used for short-range, local motility and, in this way, both cytoskeletons appear to cooperate in controlling the traffic. It has become apparent that many membranes can move along both microtubules and actin filaments and in multiple directions within the cytoskeleton (Allan and Schroer, 1999; Lambert et al., 1999) . Examining the mechanism at the molecular level remains important. We merely confirmed the colocalization of myosin V with VIP36 in this experiment. We cannot neglect the possibility that the effects of actin depolymerization agents could be due to a secondary effect. Further experiments are needed to identify the molecules working in the transport machinery.
